{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:06:51Z","timestamp":1788527211737,"version":"build-2803163510"},"reference-count":30,"publisher":"SLACK, Inc.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Ann"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:p>Children undergoing hematopoietic cell transplantation (HCT) for nonmalignant disorders are increasingly surviving long-term, shifting the focus from procedural success to durable immune recovery, infection prevention, revaccination, organ health, development, and quality of life. General pediatricians play a central role in shared care after HCT, as children transition from transplant-centered monitoring back to community-based care. Post-HCT immune recovery is heterogeneous and depends on diagnosis, donor source, graft source, conditioning, serotherapy exposure, graft-versus-host disease (GVHD), immunosuppression, and prior infections. Infection risk persists beyond neutro-phil recovery and may be prolonged in children with delayed T-cell or B-cell recovery, chronic GVHD, or ongoing immunosuppression. Revaccination is essential, as pretrans-plant immunity is often lost. This review provides a practical framework for pediatricians caring for children after nonmalignant HCT, with emphasis on infection prevention, immunization, survivorship monitoring, and the emerging role of data-driven tools to support individualized follow-up.<\/jats:p>","DOI":"10.3928\/19382359-20260630-01","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:53:25Z","timestamp":1788486805000},"source":"Crossref","is-referenced-by-count":1,"title":["Shared Care After Pediatric Nonmalignant Hematopoietic Cell Transplantation"],"prefix":"10.3928","volume":"55","author":[{"given":"Ahmed A.","family":"Shawky","sequence":"first","affiliation":[{"name":"School of Medicine, Mansoura University, Mansoura, Egypt;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H.","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"School of Medicine, Mansoura University, Mansoura, Egypt;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Elhadidy","sequence":"additional","affiliation":[{"name":"School of Medicine, Mansoura University, Mansoura, Egypt;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto D.","family":"Chiang","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M.","family":"Elsabbagh","sequence":"additional","affiliation":[{"name":"Clinical Research Program, Duke University School of Medicine, Durham, North Carolina and CITADEL Lab, Computational Immunology &amp; Transplant AI Data Engineering Lab."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01988"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01352-z"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401177"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00731-6"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-013-9917-y"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.01.009"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.178111"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00435"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00433"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.12.001"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(24)00167-6"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.5"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.01.023"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.01.003"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.06.011"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.02.025"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.12.001"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-44080-9"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.06.019"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-44080-9_29"},{"key":"e_1_3_2_22_2","volume-title":"General best practices for immunization","unstructured":"General best practices for immunization. Centers for Disease Control and Prevention. Updated July 25, 2024. Accessed July 25, 2026. https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-best-practices\/index.html"},{"key":"e_1_3_2_23_2","volume-title":"Recommended child and adolescent immunization schedule: for ages 18 years or younger, United States, 2025","unstructured":"Recommended child and adolescent immunization schedule: for ages 18 years or younger, United States, 2025. Centers for Disease Control and Prevention. Updated July 2, 2025. Accessed July 25, 2026. https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12121449"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-748426"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pix030"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30107-0"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.06.025"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16915"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1814259"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","unstructured":"Elsabbagh EM Dulanto Chiang A Alexanderani MK. ImmuneAI-CMV (Phase 1): precision phenotyping reveals heterogeneous CMV\u2013GVHD trade-offs following allogeneic HCT. Transplant Cell Ther. 2026;32(2)(suppl):S533. 10.1016\/j.jtct.2025.12.800","DOI":"10.1016\/j.jtct.2025.12.800"}],"container-title":["Pediatric Annals"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:53:28Z","timestamp":1788486808000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/19382359-20260630-01"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["10.3928\/19382359-20260630-01"],"URL":"https:\/\/doi.org\/10.3928\/19382359-20260630-01","relation":{},"ISSN":["0090-4481","1938-2359"],"issn-type":[{"value":"0090-4481","type":"print"},{"value":"1938-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}